Rhaeos is a medical technology company pioneering innovative solutions for hydrocephalus management. Their groundbreaking wearable sensor, the FlowSense™ device, offers non-invasive, real-time monitoring of cerebrospinal fluid (CSF) flow in shunt systems. This cutting-edge technology empowers healthcare providers with crucial data to optimize patient care and potentially reduce the need for invasive procedures. Rhaeos' commitment to improving the lives of hydrocephalus patients through advanced diagnostics and personalized treatment strategies has positioned them at the forefront of neurosurgical innovation. The FlowSense™ device represents a significant leap forward in hydrocephalus care, offering hope and improved outcomes for patients and their families.
.png){kind=small}
